SUNE

#4685
SUNation Energy, Inc. - Common Stock
2.1 6 USD
-0.02%
Market Price
Sektor: Technologie
Basis: USD
Gewinnwährung: USD
Tagesspanne
2.16
2.16
Jahresspanne
1.10
9.45
Tagesänderung
-1.82%
Monatliche Änderung
-4.42%
6 month change
+64.89%
Jahresänderung
+30.91%
Vorheriger Schlusskurs
2.2 0
Open
2.1 6
Tief
2.1 6
Hoch
2.1 6
Volumen
1
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik Documents

2026

Current report, Q3 FY2026
Sunation Energy, Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
Sunation Energy, Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
Sunation Energy, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Sunation Energy, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Sunation Energy, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Sunation Energy, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Sunation Energy, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Sunation Energy, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
Sunation Energy, Inc. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
Sunation Energy, Inc. current report, Q1 FY2026
8-K

Sunation Energy, Inc. current report, Q4 FY2024

Full document

SEC Filing Summary: Pineapple Energy Inc. (PEGY)

Business Context and Reporting Period

This Form 8-K was filed by Pineapple Energy Inc. (trading symbol: PEGY) on October 1, 2024. The filing addresses a regulatory notice received from The Nasdaq Stock Market regarding the company's compliance with continued listing standards. Note: The input metadata referenced "Sunation Energy, Inc.," but the filing text explicitly identifies the registrant as Pineapple Energy Inc.

Key Financial Metrics

The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity figures. The report focuses exclusively on listing compliance status.

Material Changes and Listing Status

  • Deficiency Notice: On October 1, 2024, Nasdaq notified the company that its common stock failed to maintain a minimum closing bid price of $1.00 per share for 30 consecutive business days (August 16 through September 30, 2024).
  • No Cure Period: Due to a prior hearing panel decision on July 18, 2024, the company is under a mandatory panel monitor. Consequently, Nasdaq denied the standard 180-day cure period for this deficiency.
  • Delisting Risk: Unless the company requests a hearing, its securities are subject to suspension or delisting from The Nasdaq Capital Market.

Outlook, Management Commentary, and Risks

  • Appeal Process: The company intends to request a hearing before the Nasdaq Hearings Panel by the October 8, 2024 deadline. This request will automatically stay any delisting action pending the hearing outcome.
  • Share Consolidation: Shareholders approved a share consolidation in July 2024. The Board of Directors may utilize this action to resolve the bid price deficiency before the hearing date.
  • Uncertainty: Management states there is no assurance that the Panel will grant an extension or that the company will regain compliance. Forward-looking statements regarding compliance are subject to significant risks and uncertainties.

Investor Verification Checklist

  • Verify the status of the hearing request with Nasdaq by October 8, 2024.
  • Confirm whether the Board has authorized the execution of the previously approved share consolidation.
  • Monitor the daily closing bid price of PEGY stock to see if it naturally recovers above $1.00 prior to the hearing.
  • Review the July 18, 2024 hearing panel decision details to understand the scope of the mandatory panel monitor.